A detailed history of Hickory Point Bank & Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hickory Point Bank & Trust holds 4,595 shares of BMY stock, worth $230,025. This represents 0.25% of its overall portfolio holdings.

Number of Shares
4,595
Previous 7,012 34.47%
Holding current value
$230,025
Previous $397 Million 29.34%
% of portfolio
0.25%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 14, 2025

SELL
$53.9 - $63.11 $130,276 - $152,536
-2,417 Reduced 34.47%
4,595 $280 Million
Q4 2024

Feb 05, 2025

BUY
$51.92 - $59.94 $364,063 - $420,299
7,012 New
7,012 $397 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $106B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hickory Point Bank & Trust Portfolio

Follow Hickory Point Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hickory Point Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Hickory Point Bank & Trust with notifications on news.